| Trial ID: | L0940 |
| Source ID: | NCT00851838
|
| Associated Drug: |
L-Carnitine
|
| Title: |
L-Carnitine as an Osmo-metabolic Agent for Peritoneal Dialysis
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
End-Stage Renal Disease
|
| Interventions: |
DRUG: L-Carnitine
|
| Outcome Measures: |
Primary: To assess the efficacy of L-Carnitine containing PD solution on peritoneal ultrafiltration, day 5 |
|
| Sponsor/Collaborators: |
Sponsor: Iperboreal Pharma Srl
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
5
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2009-06
|
| Completion Date: |
2012-12
|
| Results First Posted: |
|
| Last Update Posted: |
2019-06-25
|
| Locations: |
Division of Nephrology, University of "G. d'Annunzio", Chieti, Italy
|
| URL: |
https://clinicaltrials.gov/show/NCT00851838
|
